Article Versions Notes

Domingues S, Darle A, Masson Y, Saidani M, Lagoutte E, Bejanariu A, Coutier J, Ayata RE, Bouschbacher M, Peschanski M, et al. Clinical Grade Human Pluripotent Stem Cell-Derived Engineered Skin Substitutes Promote Keratinocytes Wound Closure In Vitro. Cells. 2022; 11(7):1151. https://doi.org/10.3390/cells11071151

Domingues, Sophie, Annabelle Darle, Yolande Masson, Manoubia Saidani, Emilie Lagoutte, Ana Bejanariu, Julien Coutier, Raif Eren Ayata, Marielle Bouschbacher, Marc Peschanski, and et al. 2022. "Clinical Grade Human Pluripotent Stem Cell-Derived Engineered Skin Substitutes Promote Keratinocytes Wound Closure In Vitro" Cells 11, no. 7: 1151. https://doi.org/10.3390/cells11071151

Domingues, S., Darle, A., Masson, Y., Saidani, M., Lagoutte, E., Bejanariu, A., Coutier, J., Ayata, R. E., Bouschbacher, M., Peschanski, M., Lemaitre, G., & Baldeschi, C. (2022). Clinical Grade Human Pluripotent Stem Cell-Derived Engineered Skin Substitutes Promote Keratinocytes Wound Closure In Vitro. Cells, 11(7), 1151. https://doi.org/10.3390/cells11071151